| 4WJ5: reference: Altered Peptide Ligands Revisited: Vaccine Design through Chemically Modified HLA-A2-Restricted T Cell Epitopes., Hoppes R, Oostvogels R, Luimstra JJ, Wals K, Toebes M, Bies L, Ekkebus R, Rijal P, Celie PH, Huang JH, Emmelot ME, Spaapen RM, Lokhorst H, Schumacher TN, Mutis T, Rodenko B, Ovaa H, J Immunol. 2014 Oct 13. pii: 1400800. PMID: 25311806 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).